Table 1.
Changes in clinical lipid metabolism indexes and immune-inflammatory indexes in OA patients
| Indexes | OA (n = 50) | NC (n = 30) | p |
|---|---|---|---|
| Gender (Female) | 33c | 20c | 0.951 |
| Age (years) | 55.0 (48.5, 65.25)a | 55.50 (42.75, 70.0)a | 0.952 |
| ESR (mm/h) | 19.4 (11.2, 31)a | 9.50 (5.66, 11.62)a | < 0.01 |
| TC (mmol/L) | 5.25 ± 1.29b | 2.20 (1.53, 3.10)a | < 0.01 |
| TG (mmol/L) | 1.00 (1.35, 1.73)a | 0.50 (0.34, 1.03)a | < 0.01 |
| IgA (g/L) | 2.48 ± 1.12b | 1.61 (1.20, 2.20)a | < 0.01 |
| C3 (g/L) | 1.15 ± 0.22b | 1.05 (0.94, 1.09)a | < 0.01 |
| SDS score | 53.09 ± 7.11b | NA | - |
| VAS score | 5.72 ± 0.60b | - | - |
| SAS score | 43.38 (40.62, 47.67)a | - | - |
aWilcoxon signed-rank test, median (25–75th percentile)
bmean ± standard error
cchi-square test
NC healthy control; OA osteoarthritis; NA not applicable; ESR erythrocyte sedimentation rate; TC total cholesterol; TG triglyceride; IgA immunoglobulin A; C3 complement C3; SDS Self-rating Depression Scale; SAS Self-rating Anxiety Scale; VAS Visual Analog Scale